Inhibition of SARS-CoV-2 infection by Porphyromonas gingivalis and the oral microbiome
Alexander Bontempo, Alexandra Chirino, Alireza Heidari, Alexandra Lugo, Satoru Shindo, Maria Rita Pastore, Riccardo Madonia, Sibel A. Antonson, Cristina Godoy, Frank C. Nichols, Jan Potempa, Mary Ellen Davey, Toshihisa Kawai, Mark J. Cayabyab
This study shows that Porphyromonas gingivalis and other oral bacteria can inhibit SARS-CoV-2 infection through cytotoxicity and unknown mechanisms, with individual variation in oral microbiome activity.
Microbiology Spectrum · Aug 20, 2024Peer-reviewedMicrobiology